Prevention of early ventilation-acquired pneumonia (VAP) in comatose brain-injured patients by a single dose of ceftriaxone: PROPHY-VAP study protocol, a multicentre, randomised, double-blind, placebo-controlled trial

INTRODUCTION: Ventilator-associated pneumonia (VAP) is the first cause of healthcare-associated infections in intensive care units (ICUs) and brain injury is one of the main risk factors for early-onset VAP. Antibiotic prophylaxis has been reported to decrease their occurrence in brain-injured patie...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:BMJ Open
المؤلفون الرئيسيون: Dahyot-Fizelier, Claire, Frasca, Denis, Lasocki, Sigismond, Asehnoune, Karim, Balayn, Dorothée, Guerin, Anne-Laure, Perrigault, Pierre-François, Geeraerts, Thomas, Seguin, Philippe, Rozec, Bertrand, Elaroussi, Djilali, Cottenceau, Vincent, Guyonnaud, Clément, Mimoz, Olivier
التنسيق: Artigo
اللغة:Inglês
منشور في: BMJ Publishing Group 2018
الموضوعات:
Intensive Care
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC6196869/
https://ncbi.nlm.nih.gov/pubmed/30341115
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2018-021488
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة